Galderma

“When you hit peri- and post-menopause, these can truly be your most beautiful years,” says board-certified dermatologist Dr. Doris Day, MD, “as long as we separate out the idea that we're going to try to look 20 again.” Despite affecting around half of the world’s population, menopause is still an under-addressed and understudied topic. Women of menopausal age who report life-altering symptoms are often not taken seriously – and that’s something that needs to change, says Dr. Day. She is a key voice among a growing network of dermatologists who are changing the narrative around menopause and the need for better support. Galderma’s commitment to improving the lives of those navigating menopause is motivated by our in-depth discussions with experts like Dr. Day to understand the lived experience of women. Watch this year’s last episode of Beauty x Medicine, hosted by our CEO, Flemming Ornskov, MD, MPH, to learn more about the challenges of menopause and the power of aesthetic medicine to change lives for the better. We would like to thank Dr. Day and all the experts that joined the series this year, and look forward to hearing insights from more leading voices in 2026. #AdvancingDermatology #BeautyXMedicine #menopause

#PrurigoNodularis has historically been misunderstood, even mistaken for a psychological disorder.    We now understand more about the complex interactions between the skin, nerves, and immune system that drive the disease – but there’s still much more to uncover.    Let’s keep collaborating across the dermatology community and advancing understanding of prurigo nodularis.    #AdvancingDermatology #SkinScienceByGalderma  

For 10 years, the Galderma Aesthetic Injector Network (#GAIN) has championed a personalized, patient-centric approach. Now a global force in aesthetics, GAIN empowers healthcare professionals to tailor their treatments to each individual’s unique needs. By moving away from one-size-fits-all methods to science-backed, individualized care, physicians can enhance outcomes and patient satisfaction. Dr. Simone Doreian and Dr. Keywan Taghetchian, MD, MBA explain here how GAIN is more than just a training program: it is a community dedicated to advancing dermatology through its expertise and patient care. We look forward to what the next decade of GAIN will bring. #AdvancingDermatology #GAIN10years

Continuing education is a foundational tool of medicine. Our U.S.-born industry-leading Galderma Aesthetic Injector Network (GAIN) is dedicated to training healthcare professionals in the most advanced techniques in medical aesthetics. GAIN has celebrated its 10-year anniversary this year by setting new benchmarks. This network of highly-trained practitioners has continued on its journey to empower a community of aesthetic injectors. In 2025 so far, around 400 experts have trained more than 10,000 injectors at GAIN events across the U.S., teaching the skills necessary to achieve optimal results with individualized treatments. Training is fundamental to ensuring that patient and consumer needs are met with outstanding results. GAIN and our specialist teams are pleased to support the scientific community with the most advanced tools from the forefront of the field. #AdvancingDermatology #USinvestment

Quando il prurito è una sfida quotidiana. Come immaginate che sarebbe la vostra vita se provaste un prurito costante che non dura qualche minuto o ora, ma settimane o mesi? Purtroppo, questa è la realtà delle persone affette da dermatite atopica (DA) o prurigo nodularis (PN), che, a causa del prurito, vivono svariate difficoltà quotidiane. Il prurito cronico causa danni fisici, psicologici e sociali sia nei pazienti sia nei loro familiari, compromettendo la qualità della vita, il sonno, le relazioni, il rendimento lavorativo e scolastico, e portando spesso ad ansia e depressione. L’interleuchina 31 (IL-31) è una citochina chiave sia nella DA sia nella PN, per il suo ruolo nella stimolazione del prurito, dell'infiammazione e del danneggiamento della barriera cutanea. Risulta evidente come il controllo del prurito e dell'infiammazione, e il ripristino dell'integrità della barriera cutanea nei pazienti affetti da DA o PN siano fondamentali e come questo richieda una migliore comprensione dei meccanismi alla base delle patologie infiammatorie cutanee croniche.    

We’re proud to share new ASDS 2025 data highlighting the versatility of our Restylane® portfolio and how it can be used with Sculptra® to deliver aesthetic improvements for patients experiencing facial aesthetic changes after medication-driven weight loss. These findings, along with additional data and our educational sessions, reinforce our leadership in science-backed aesthetics and our commitment to helping practitioners achieve meaningful outcomes. https://lnkd.in/eTdzjTs6

Galderma completes successful placement of CHF 175 million bond. The successful issuance is leverage-neutral and does not materially affect Galderma’s full-year 2025 guidance on net financial expenses, as last communicated in the first half 2025 results on July 24, 2025. Read the press release for more details: https://lnkd.in/edCkyeSz

For years, Eugenia lived with unexplained symptoms, persistent nodules and relentless itch without answers.    Her story is a powerful reminder of the diagnostic challenges many #PrurigoNodularis patients face, and the importance of raising awareness around this disease.    #AdvancingDermatology   #SkinScienceByGalderma  

We’re excited to join the dermatologic surgery community at the American Society for Dermatologic Surgery Annual Meeting 2025 in Chicago this week! We will present six scientific posters and host educational sessions spotlighting our holistic approach to addressing unmet patient needs. Stay tuned for updates as we continue to advance the science of aesthetics. Find out more about our activities: https://lnkd.in/eGg_rBf5

Medication-driven weight loss can sometimes cause changes in the skin of the face. From dry, dull, or sagging skin to a gaunt or hollowed-out facial appearance, these changes can take patients by surprise and may negatively impact how they feel about their new appearance.    Find out more about the science behind these skin changes and guidance for aesthetic clinicians on how to best support patients via the report on our website: https://lnkd.in/gx7GJnKR